| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Head Of International
1 company
Mazabraud Yann is an EVP, Head Of International at RHYTHM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $6.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sell | 6,745 | $65.08 | $438,946.39 | -15.2% | +31.4% | +25.9% | |
| Apr 8, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sell | 17,750 | $60.99 | $1,082,497.31 | -24.5% | +15.0% | +48.1% | |
| Mar 14, 2025 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sale+OE | 75,000 | $51.48 | $3,861,272.37 | -35.5% | +23.6% | +71.4% | |
| Mar 19, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sell | 16,000 | $39.22 | $627,520.00 | -39.5% | +5.2% | +41.1% | |
| Feb 13, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sale+OE | 2,551 | $50.80 | $129,596.60 | -15.0% | -17.8% | +17.9% | |
| Feb 14, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sell | 1,177 | $27.03 | $31,814.31 | -23.5% | -38.1% | +83.5% | |
| Feb 9, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sale+OE | 1,548 | $27.66 | $42,817.68 | -34.1% | -37.0% | +85.0% | |
| Feb 15, 2022 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head Of International | Sale+OE | 934 | $6.10 | $5,697.40 | -46.0% | -52.6% | +288.2% |